Literature DB >> 28783477

A High-Content Live-Cell Viability Assay and Its Validation on a Diverse 12K Compound Screen.

Jeanne Chiaravalli1, J Fraser Glickman1.   

Abstract

We have developed a new high-content cytotoxicity assay using live cells, called "ImageTOX." We used a high-throughput fluorescence microscope system, image segmentation software, and the combination of Hoechst 33342 and SYTO 17 to simultaneously score the relative size and the intensity of the nuclei, the nuclear membrane permeability, and the cell number in a 384-well microplate format. We then performed a screen of 12,668 diverse compounds and compared the results to a standard cytotoxicity assay. The ImageTOX assay identified similar sets of compounds to the standard cytotoxicity assay, while identifying more compounds having adverse effects on cell structure, earlier in treatment time. The ImageTOX assay uses inexpensive commercially available reagents and facilitates the use of live cells in toxicity screens. Furthermore, we show that we can measure the kinetic profile of compound toxicity in a high-content, high-throughput format, following the same set of cells over an extended period of time.

Entities:  

Keywords:  SYTO 17; assay validation; cytotoxicity; high-content screening; live-cell assays

Year:  2017        PMID: 28783477     DOI: 10.1177/2472555217724745

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  1 in total

1.  HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.

Authors:  Alison Howarth; Martin Schröder; Raquel C Montenegro; David H Drewry; Heba Sailem; Val Millar; Susanne Müller; Daniel V Ebner
Journal:  SLAS Discov       Date:  2020-05-27       Impact factor: 3.341

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.